DK207889A - Farmaceutisk praeparat med anti-cancer virkning - Google Patents

Farmaceutisk praeparat med anti-cancer virkning Download PDF

Info

Publication number: DK207889A
Authority: DK; Denmark
Prior art keywords: pharmaceutical preparation; cancer effect; ascorbic acid; cancer; benzylidene
Prior art date: 1988-04-29

Application number

DK207889A

Other languages

Danish (da)

English (en)

Other versions

DK207889D0 (da

Inventor

Reidar Oftebro

Erik Olai Pettersen

John Michael Dornish

Bernt Boerretzen

Rolf Olav Larsen

Original Assignee

Norsk Hydro As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-04-29

Filing date

1989-04-28

Publication date

1989-10-30

1989-04-28 Application filed by Norsk Hydro As filed Critical Norsk Hydro As

1989-04-28 Publication of DK207889D0 publication Critical patent/DK207889D0/da

1989-10-30 Publication of DK207889A publication Critical patent/DK207889A/da

Links

230000001093 anti-cancer Effects 0.000 title abstract 2
239000000825 pharmaceutical preparation Substances 0.000 title 1
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
SWTGJCNCBUCXSS-ISUZDFFFSA-N (2r)-3,4-dihydroxy-2-[(4s)-2-phenyl-1,3-dioxolan-4-yl]-2h-furan-5-one Chemical compound OC1=C(O)C(=O)O[C@@H]1[C@H]1OC(C=2C=CC=CC=2)OC1 SWTGJCNCBUCXSS-ISUZDFFFSA-N 0.000 abstract 1
239000002211 L-ascorbic acid Substances 0.000 abstract 1
235000000069 L-ascorbic acid Nutrition 0.000 abstract 1
230000000259 anti-tumor effect Effects 0.000 abstract 1
229960005070 ascorbic acid Drugs 0.000 abstract 1
DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 abstract 1
229960004316 cisplatin Drugs 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
150000003057 platinum Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Inorganic Chemistry (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK207889A 1988-04-29 1989-04-28 Farmaceutisk praeparat med anti-cancer virkning DK207889A (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB888810173A GB8810173D0 (en)	1988-04-29	1988-04-29	Pharmaceutical compositions with anti-cancer activity & method for treatment of cancer

Publications (2)

Publication Number	Publication Date
DK207889D0 DK207889D0 (da)	1989-04-28
DK207889A true DK207889A (da)	1989-10-30

Family

ID=10636096

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK207889A DK207889A (da)	1988-04-29	1989-04-28	Farmaceutisk praeparat med anti-cancer virkning

Country Status (11)

Country	Link
US (2)	US5049396A (de)
EP (1)	EP0344880B1 (de)
JP (1)	JPH0296524A (de)
AT (1)	ATE79757T1 (de)
AU (1)	AU618997B2 (de)
CA (1)	CA1326441C (de)
DE (1)	DE68902581T2 (de)
DK (1)	DK207889A (de)
ES (1)	ES2051997T3 (de)
GB (1)	GB8810173D0 (de)
GR (1)	GR3006004T3 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9026114D0 (en) *	1990-11-30	1991-01-16	Norsk Hydro As	New compounds
CA2122342A1 (en) *	1992-09-04	1994-03-17	Hironori Kawabata	Pharmaceutical composition
KR100477070B1 (ko) *	1994-03-25	2006-04-21	이소테크니카 인코포레이티드	중수소화작용에의한의약품의효능강화법
US6334997B1 (en) *	1994-03-25	2002-01-01	Isotechnika, Inc.	Method of using deuterated calcium channel blockers
US5955498A (en) *	1994-04-27	1999-09-21	Tanuma; Sei-Ichi	Agent for prophylaxis and therapy of diseases
JP2990015B2 (ja) *	1994-06-20	1999-12-13	睦之東風	抗ｈｉｖ剤
DE4427690A1 (de) *	1994-08-04	1996-02-08	Bogdahn Ulrich Prof	Deuterium enthaltende pharmazeutische Zusammensetzung als Zytostatikum oder Tumor-Therapeutikum
US5639787A (en) *	1995-02-28	1997-06-17	The Center For The Improvement Of Human Functioning Int'l, Inc.	Therapeutic method for the treatment of cancer
EP1002535A1 (de) *	1998-10-28	2000-05-24	Hrissanthi Ikonomidou	Neue Verwendung von Glutamat-Antagonisten zur Behandlung von Krebs
JP4776843B2 (ja)	1999-10-01	2011-09-21	イムノゲンインコーポレーティッド	免疫複合体及び化学療法剤を用いる癌治療用組成物及び方法
US6573050B1 (en)	1999-10-29	2003-06-03	Sunnybrook & Women's College Health Sciences Centre	Treatment, diagnosis and evaluation of anti-cancer therapy resistance in melanoma
AUPQ641100A0 (en) *	2000-03-23	2000-04-15	Australia Nuclear Science & Technology Organisation	Methods of synthesis and use of radiolabelled platinum chemotherapeutic ag ents
US6468980B1 (en) *	2000-09-01	2002-10-22	Oxycal Laboratories, Inc.	Methods and compositions for potentiating cancer chemotherapeutic agents
US20050220899A1 (en) *	2002-05-07	2005-10-06	Clet Niyikiza	Use of cisplatin in combination with folic acid for increasing cisplatin efficacy
CZ300795B6 (cs) *	2003-09-02	2009-08-12	Pliva-Lachema A. S.	Farmaceutická kompozice a zpusob její výroby
US20060275504A1 (en) *	2005-06-07	2006-12-07	Tty Biopharm Company Limited	Methods and compositions for augmenting cancer chemotherapeutic agents
RU2319491C1 (ru) *	2006-07-12	2008-03-20	Бадулин Николай Александрович	Противоопухолевая, антибактериальная и антивирусная фармацевтическая композиция (ее варианты)
EP2598114A1 (de) *	2010-07-28	2013-06-05	Fondazione Irccs "Istituto Nazionale del Tumori"	Therapeutikum, zusammensetzung damit, implantierbare vorrichtung und verfahren für die behandlung von zervixkarzinom und/oder die prävention von neoplasmen der zervix eines weiblichen genitalsystems beim menschen
US20140065096A1 (en) *	2012-09-05	2014-03-06	Regen BioPharma, Inc.	Cancer therapy by ex vivo activated autologous immune cells

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4457926A (en) *	1979-06-20	1984-07-03	Engelhard Corporation	Cis-Platinum(II) amine ascorbate complexes
JPS60139619A (ja) *	1983-12-27	1985-07-24	Mutsuyuki Kochi	Ｏ−ベンジリデン−アスコルビン酸又はその塩よりなる抗腫瘍剤

1988
- 1988-04-29 GB GB888810173A patent/GB8810173D0/en active Pending
1989
- 1989-02-23 ES ES89301763T patent/ES2051997T3/es not_active Expired - Lifetime
- 1989-02-23 AT AT89301763T patent/ATE79757T1/de not_active IP Right Cessation
- 1989-02-23 DE DE8989301763T patent/DE68902581T2/de not_active Expired - Lifetime
- 1989-02-23 EP EP89301763A patent/EP0344880B1/de not_active Expired - Lifetime
- 1989-03-27 US US07/329,379 patent/US5049396A/en not_active Expired - Fee Related
- 1989-04-03 CA CA000595474A patent/CA1326441C/en not_active Expired - Fee Related
- 1989-04-05 AU AU32454/89A patent/AU618997B2/en not_active Ceased
- 1989-04-28 JP JP1107973A patent/JPH0296524A/ja active Pending
- 1989-04-28 DK DK207889A patent/DK207889A/da not_active Application Discontinuation
1991
- 1991-06-20 US US07/718,363 patent/US5130145A/en not_active Expired - Fee Related
1992
- 1992-10-15 GR GR920402324T patent/GR3006004T3/el unknown

Also Published As

Publication number	Publication date
US5049396A (en)	1991-09-17
AU618997B2 (en)	1992-01-16
DE68902581D1 (de)	1992-10-01
EP0344880A2 (de)	1989-12-06
JPH0296524A (ja)	1990-04-09
CA1326441C (en)	1994-01-25
DK207889D0 (da)	1989-04-28
GR3006004T3 (de)	1993-06-21
EP0344880A3 (en)	1990-04-18
ES2051997T3 (es)	1994-07-01
DE68902581T2 (de)	1992-12-24
ATE79757T1 (de)	1992-09-15
AU3245489A (en)	1989-11-02
GB8810173D0 (en)	1988-06-02
EP0344880B1 (de)	1992-08-26
US5130145A (en)	1992-07-14

Similar Documents

Publication	Publication Date	Title
DK207889D0 (da)	1989-04-28	Farmaceutisk praeparat med anti-cancer virkning
IL89840A0 (en)	1989-12-15	Substituted flavonoid compounds and salts thereof,their preparation and pharmaceutical compositions containing them
DE3883016D1 (de)	1993-09-16	Komplexe verbindungen aus bioflavonoiden mit phospholipiden, ihre herstellung und verwendung und sie enthaltende pharmazeutische und kosmetische zusammensetzungen.
NO2002009I2 (no)	2004-10-11	Tiotropium
DK403587A (da)	1988-02-05	Acetyl-l-carnitin til anvendelse til behandling af perifere neuropathier
ATE66614T1 (de)	1991-09-15	Insulinzubereitung fuer nicht-parenterale verabreichung.
GR3017282T3 (en)	1995-11-30	Novel arylpyridazines, their manufacture, use and medicaments containing them.
DE3871407D1 (de)	1992-07-02	Haltbare interferonkomplexe.
ATE81588T1 (de)	1992-11-15	Vasokinetisch wirkende polyungesaettigte saeuren und sie enthaltende pharmazeutische oder kosmetische zubereitungen.
DE59410151D1 (de)	2002-08-14	Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe
IT1215332B (it)	1990-02-08	Composizione farmaceutica contenente sulglicotide per la terapia dell'ulcera gastrica
EP0191724A3 (de)	1986-12-03	1,4-Dihydropyridine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
ATE90685T1 (de)	1993-07-15	Disaccharidderivate.
LV10051A (lv)	1994-05-10	Liofilizeta ifosfamida iegusanas veids
IL84551A0 (en)	1988-04-29	Peptides,their preparation and pharmaceutical compositions containing them
MY105876A (en)	1995-02-28	Pharmaceutical compositions with anti-cancer activity and method for the treatment of cancer.
DE68901656D1 (de)	1992-07-09	Pharmazeutische zusammensetzung zur milderung der nebenwirkungen von platinhaltigen arzneimitteln.
FR2694005B1 (fr)	1994-08-26	Nouvelles aminoalkylchromones, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
ATE36957T1 (de)	1988-09-15	N,n-diethyl-5-methyl-2h,1-benzothiopyrano-(4,3, - cd)-indazol-2-ethanamine, diese enthaltende zubereitungen und ihre verwendung.
DE68906437D1 (de)	1993-06-17	L-pyroglutamyl-l-cystein-dipeptid mit hoher anti-cataractogener wirkung und dies enthaltende pharmazeutische zusammensetzungen.
ATE80873T1 (de)	1992-10-15	Tetrahydropyridin-derivate.
IT8622051A1 (it)	1988-04-17	Composizioni farmaceutiche ad attivita' cicatrizzante
IE45326L (en)	1978-02-02	Gold-containing pharmaceutical composition
ATE87314T1 (de)	1993-04-15	Platin-arzneimittel.
ATE61226T1 (de)	1991-03-15	Pharmazeutische zusammensetzungen mit antineoplastischer wirkung.

Legal Events

Date	Code	Title	Description
1995-11-06	ATS	Application withdrawn